Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 17, 2020
It’s also become increasingly clear that while regional compacts represent an important new tool in MCC’s toolbox, they’re likely to remain a limited part of the agency’s overall portfolio, in large part because of MCC’s country eligibility requirements. This blog outlines the limitations and poses ...
Blog Post
December 09, 2020
On December 15, the Millennium Challenge Corporation’s board of directors will hold its annual country selection meeting (the last of the Trump administration), identifying which countries will be made newly eligible for the agency’s funding. Every year CGD’s US Development Policy team highlights ke...
CGD NOTES
December 07, 2020
The SARS-COV-2/COVID-19 pandemic has created an unprecedented public health challenge, spurring a global race to develop and distribute viable vaccines. By mid-2021, there will likely be multiple licensed vaccines. Although there is an urgent need for these vaccines to be made available, several cri...
Blog Post
November 25, 2020
As COVID-19 vaccines begin to emerge, policymakers around the world are feeling buoyant. Although governments will be the initial recipients of vaccines, their decisions on how to distribute these among their populations will be fundamental for the ultimate recipients: individuals.
Blog Post
November 09, 2020
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/...